Funding for this research was provided by:
The project was supported by Starting Research Funding from Xinxiang Medical University
Article History
Received: 17 January 2022
Accepted: 6 October 2022
First Online: 21 October 2022
Declarations
:
: The authors declare no conflicts of interest.
: This usage of clinical samples was reviewed and approved by the Ethical Board at Zhengzhou University with written informed consent from all the patients. All animal experiments involved in this study were approved by the Ethics Committee of Zhengzhou University. All methods were carried out in accordance with relevant guidelines and regulations. The study is reported in accordance with the ARRIVE guidelines. The approval number of your clinical study and that of animal study is 2022-KY-1143-002.